IFLR1000

Bristol-Myers Squibb $1.5 billion notes issue

28/2/2017
Investment grade bond/note issue
Select tab

$ 1.5 billion

Completed

28/2/2017

Overview:

  • Pharmaceutical company Bristol-Myers Squibb has made a $1.5 billion notes issue.
  • The offering consisted of $750 million 1.60% notes due 2019 and $750 million 3.250% notes due 2027.
  • Underwriters included Goldman Sachs, Morgan Stanley, Bank of America Merrill Lynch, JPMorgan and Citigroup.

Kurt Stumpo - Journalist

Jurisdiction:

United States

Deal type:

Investment grade bond/note issue

Practice area:

Capital markets : Debt

Governing law:

United States

Industry sector:

Pharmaceuticals and life sciences

Firms:
Covington & Burling

Party: Bristol-Myers Squibb (Issuer)

Davis Polk & Wardwell

Party: Goldman Sachs (Underwriter)

Party: Morgan Stanley (Underwriter)

Party: BofA Merrill Lynch (Underwriter)

Party: JP Morgan (Underwriter)

Party: Citigroup (Underwriter)

Lawyer: Richard Truesdell Jr

Related deals